Breaking Finance News

Crocs (NASDAQ:CROX) has been downgraded from Buy to Neutral in a statement by CL King earlier today.

Having a price of $10.20, Crocs (NASDAQ:CROX) traded -2.19% lower on the day. With the last close up 28.75% from the two hundred day average, compared with the S&P 500 Index which has increased 0.01% over the same period. Crocs has recorded a 50-day average of $8.59 and a two hundred day average of $7.28. Volume of trade was up over the average, with 1,200,762 shares of CROX changing hands over the typical 1,096,490

CL King has downgraded Crocs (NASDAQ:CROX) from Buy to Neutral in a statement released on Monday November 20, 2017.

Performance Chart


With a total market value of $0, Crocs has with a one year low of $5.93 and a one year high of $9.70 .

A total of 8 analysts have released a report on Crocs. Two analysts rating the company a strong buy, one analyst rating the company a buy, six analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $11.00.

More About Crocs (NASDAQ:CROX)

Crocs, Inc. is engaged in the design, development, manufacturing, marketing, distribution and sale of casual lifestyle footwear and accessories for men, women, and children. The Company's segments include Americas, Asia Pacific and Europe. Its products include footwear and accessories that utilize its closed-cell resin, called Croslite, as well as casual lifestyle footwear that use a range of materials. Its Croslite material enables the Company to produce non-marking, and odor-resistant footwear. As of December 31, 2016, the Company sold its products in over 90 countries through domestic and international retailers and distributors, and directly to consumers through its company-operated retail stores, outlets, e-commerce store sites and kiosks. The Company's sales channels include wholesale, which includes distributors, Crocs owned retail and Crocs e-commerce.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.